Aetna Stock Price, News & Analysis (NYSE:AET)

$185.49 0.39 (0.21 %)
(As of 01/18/2018 04:00 PM ET)
Previous Close$185.49
Today's Range$184.88 - $186.41
52-Week Range$116.04 - $192.37
Volume2.22 million shs
Average Volume2.88 million shs
Market Capitalization$60.49 billion
P/E Ratio34.29
Dividend Yield1.08%
Beta0.61

About Aetna (NYSE:AET)

Aetna logoAetna Inc. is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers' compensation administrative services and health information technology (HIT) products and services. The Health Care segment consists of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an Insured basis and an employer-funded basis, and emerging businesses products and services. The Group Insurance segment includes group life insurance and group disability products. Its products are offered on an Insured basis.

Receive AET News and Ratings via Email

Sign-up to receive the latest news and ratings for AET and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Managed Health Care
Sub-IndustryManaged Health Care
SectorHealthcare
SymbolNYSE:AET
CUSIP00817Y10
Phone+1-860-2730123

Debt

Debt-to-Equity Ratio0.52%
Current Ratio0.53%
Quick Ratio0.53%

Price-To-Earnings

Trailing P/E Ratio34.2865064695009
Forward P/E Ratio18.97
P/E Growth1.58

Sales & Book Value

Annual Sales$63.16 billion
Price / Sales0.96
Cash Flow$10.50 per share
Price / Cash17.67
Book Value$51.13 per share
Price / Book3.63

Profitability

Trailing EPS$5.41
Net Income$2.27 billion
Net Margins2.93%
Return on Equity21.84%
Return on Assets5.80%

Miscellaneous

Employees49,500
Outstanding Shares326,170,000

Aetna (NYSE:AET) Frequently Asked Questions

What is Aetna's stock symbol?

Aetna trades on the New York Stock Exchange (NYSE) under the ticker symbol "AET."

How often does Aetna pay dividends? What is the dividend yield for Aetna?

Aetna announced a quarterly dividend on Monday, December 4th. Shareholders of record on Thursday, January 11th will be paid a dividend of $0.50 per share on Friday, January 26th. This represents a $2.00 dividend on an annualized basis and a yield of 1.08%. The ex-dividend date is Wednesday, January 10th. View Aetna's Dividend History.

How will Aetna's stock buyback program work?

Aetna declared that its Board of Directors has initiated a stock buyback program on Friday, April 7th 2017, which authorizes the company to buyback $4,000,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to purchase up to 98% of its stock through open market purchases. Stock buyback programs are usually an indication that the company's leadership believes its shares are undervalued.

How were Aetna's earnings last quarter?

Aetna Inc (NYSE:AET) announced its quarterly earnings results on Tuesday, October, 31st. The company reported $2.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.06 by $0.39. The firm earned $14.99 billion during the quarter, compared to the consensus estimate of $15.12 billion. Aetna had a net margin of 2.93% and a return on equity of 21.84%. The firm's quarterly revenue was down 5.0% on a year-over-year basis. During the same period in the prior year, the company posted $2.07 EPS. View Aetna's Earnings History.

When will Aetna make its next earnings announcement?

Aetna is scheduled to release their next quarterly earnings announcement on Tuesday, January, 30th 2018. View Earnings Estimates for Aetna.

What guidance has Aetna issued on next quarter's earnings?

Aetna issued an update on its FY17 earnings guidance on Tuesday, October, 31st. The company provided EPS guidance of ~$9.75 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $9.56.

Where is Aetna's stock going? Where will Aetna's stock price be in 2018?

21 equities research analysts have issued 12 month target prices for Aetna's stock. Their predictions range from $135.00 to $208.00. On average, they expect Aetna's share price to reach $175.71 in the next year. View Analyst Ratings for Aetna.

What are Wall Street analysts saying about Aetna stock?

Here are some recent quotes from research analysts about Aetna stock:

  • 1. According to Zacks Investment Research, "Aetna’s third-quarter earnings surpassed the Zacks Consensus Estimate and grew year over year, driven by strong underwriting margin performance, disciplined pricing, a focus on high quality care management, and a decline in medical cost. Aetna’s shares have outperformed the industry year to date. We expect the company to witness long-term growth from its Government business and International expansion. Its cost-reduction initiatives will aid margins. The sale of its Group Life and Disability business will help it to focus on core growth areas. Following strong third-quarter results, Aetna raised its earnings guidance, cementing investors' confidence in it. Aetna has, however, been incurring losses in its public exchange business and has been exiting exchanges. Furthermore, its membership growth remains under pressure. Increasing medical benefit ratios are also likely to hurt margins." (11/2/2017)
  • 2. Cantor Fitzgerald analysts commented, "There is life after Humana. CEO Mark Bertolini opened the meeting discussing life after Humana. With a continued focus to grow its government business, Mr. Bertolini indicated that Humana represented a means to an end." Instead, AET will now chose to build its government business organically. We believe the company will also pursue acquisitions to build out its capabilities in specific geographies. CFO Shawn Guertin identified Medicare as a great growth opportunity, but characterized Medicaid as a good opportunity. Growth in Medicaid slowed recently due to two contract losses and potential for structural changes to Medicaid exist." (5/12/2017)
  • 3. Royal Bank of Canada analysts commented, "After the close on Monday, April 24, Humana pre-released 1Q17 EPS ahead of its investor meeting, which will be held on Tuesday, April 25. 1Q17 Adjusted EPS for the quarter was $2.75 vs. our estimate of $2.50 and FactSet consensus of $2.49." (4/24/2017)
  • 4. Oppenheimer Holdings Inc. analysts commented, "Overall, we believe Humana is well positioned for growth, given the political support in Washington, ample strategic capital to deploy and the potential for upside to its current earnings base."Ultimately, this will also remain a desirable asset that could be acquired by another insurer." (3/31/2017)

Who are some of Aetna's key competitors?

Who are Aetna's key executives?

Aetna's management team includes the folowing people:

  • Mark T. Bertolini, Chairman of the Board, Chief Executive Officer (Age 60)
  • Karen S. Lynch, President (Age 54)
  • Shawn M. Guertin, Chief Financial Officer, Executive Vice President, Chief Enterprise Risk Officer (Age 53)
  • Thomas J. Sabatino Jr., Executive Vice President, General Counsel (Age 58)
  • Gary W. Loveman Ph.D., Executive Vice President - Consumer and Health Services (Age 56)
  • Margaret M. McCarthy, Executive Vice President - Operations and Technology (Age 63)
  • Harold L. Paz M.D., Executive Vice President, Chief Medical Officer (Age 62)
  • Francis S. Soistman Jr., Executive Vice President - Government Services (Age 60)
  • Heather Dixon, Chief Accounting Officer, Vice President, Controller (Age 45)
  • Edward J. Ludwig, Lead Independent Director (Age 65)

Who owns Aetna stock?

Aetna's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Schwab Charles Investment Management Inc. (0.38%), Acadian Asset Management LLC (0.20%), Bank of Montreal Can (0.14%), Gateway Investment Advisers LLC (0.09%), National Pension Service (0.09%) and KAMES CAPITAL plc (0.08%). Company insiders that own Aetna stock include Francis S Soistman Jr, Gary W Loveman, Jeffrey E Garten, Karen S Lynch, Margaret M Mccarthy, Mark T Bertolini, Molly Joel Coye and Shawn M Guertin. View Institutional Ownership Trends for Aetna.

Who sold Aetna stock? Who is selling Aetna stock?

Aetna's stock was sold by a variety of institutional investors in the last quarter, including Atalanta Sosnoff Capital LLC, Sit Investment Associates Inc., DnB Asset Management AS, Westpac Banking Corp, Profit Investment Management LLC, Exxonmobil Investment Management Inc. TX, Oakbrook Investments LLC and National Pension Service. Company insiders that have sold Aetna company stock in the last year include Francis S Soistman Jr, Karen S Lynch, Margaret M Mccarthy, Mark T Bertolini and Shawn M Guertin. View Insider Buying and Selling for Aetna.

Who bought Aetna stock? Who is buying Aetna stock?

Aetna's stock was acquired by a variety of institutional investors in the last quarter, including Milestone Resources Group Ltd, Bank of Montreal Can, Factory Mutual Insurance Co., Acadian Asset Management LLC, KAMES CAPITAL plc, Schwab Charles Investment Management Inc., Havens Advisors LLC and Koshinski Asset Management Inc.. View Insider Buying and Selling for Aetna.

How do I buy Aetna stock?

Shares of Aetna can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Aetna's stock price today?

One share of Aetna stock can currently be purchased for approximately $185.49.

How big of a company is Aetna?

Aetna has a market capitalization of $60.49 billion and generates $63.16 billion in revenue each year. The company earns $2.27 billion in net income (profit) each year or $5.41 on an earnings per share basis. Aetna employs 49,500 workers across the globe.

How can I contact Aetna?

Aetna's mailing address is 151 Farmington Ave, HARTFORD, CT 06156-0001, United States. The company can be reached via phone at +1-860-2730123 or via email at [email protected]


MarketBeat Community Rating for Aetna (AET)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  682 (Vote Outperform)
Underperform Votes:  450 (Vote Underperform)
Total Votes:  1,132
MarketBeat's community ratings are surveys of what our community members think about Aetna and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Aetna (NYSE:AET) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.572.572.682.70
Ratings Breakdown: 0 Sell Rating(s)
9 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
9 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $175.71$178.71$163.69$153.24
Price Target Upside: 2.76% downside0.01% upside8.09% upside1.16% downside

Aetna (NYSE:AET) Consensus Price Target History

Price Target History for Aetna (NYSE:AET)

Aetna (NYSE:AET) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/3/2018Piper Jaffray CompaniesUpgradeNeutral -> Overweight$136.00LowView Rating Details
12/20/2017Morgan StanleyDowngradeOverweight -> Equal Weight$179.00LowView Rating Details
12/6/2017Credit Suisse GroupReiterated RatingNeutral$174.00 -> $195.00LowView Rating Details
12/6/2017ArgusDowngradeBuy -> Hold$185.00LowView Rating Details
12/4/2017Wells Fargo & CoReiterated RatingOutperform$200.00 -> $208.00HighView Rating Details
11/3/2017Raymond James FinancialUpgradeMarket Perform -> Outperform$200.00N/AView Rating Details
11/2/2017CitigroupBoost Price TargetBuy$183.00 -> $197.00N/AView Rating Details
11/1/2017Jefferies GroupBoost Price TargetHold$165.00 -> $185.00N/AView Rating Details
10/27/2017BMO Capital MarketsBoost Price TargetMarket Perform$175.00 -> $200.00N/AView Rating Details
10/26/2017Cantor FitzgeraldDowngradeOverweight -> NeutralN/AView Rating Details
8/7/2017Deutsche BankBoost Price TargetHold$157.00 -> $163.00LowView Rating Details
8/4/2017Royal Bank of CanadaBoost Price TargetOutperform -> Outperform$162.00 -> $171.00MediumView Rating Details
5/27/2017CowenSet Price TargetBuy$145.00 -> $170.00N/AView Rating Details
5/17/2017Bank of AmericaReiterated RatingBuy$160.00 -> $168.00MediumView Rating Details
5/16/2017Stifel NicolausBoost Price TargetBuy -> Buy$150.00 -> $158.00LowView Rating Details
5/15/2017BarclaysReiterated RatingOverweight$162.00LowView Rating Details
5/11/2017Cleveland ResearchUpgradeNeutral -> BuyLowView Rating Details
4/3/2017CIBCReiterated RatingOutperformLowView Rating Details
3/31/2017OppenheimerReiterated RatingOutperformLowView Rating Details
1/31/2017Sanford C. BernsteinDowngradeOutperform -> Market PerformN/AView Rating Details
1/24/2017Leerink SwannDowngradeOutperform -> Market Perform$135.00N/AView Rating Details
9/22/2016Evercore ISIInitiated CoverageBuy$128.00N/AView Rating Details
8/17/2016FBR & CoReiterated RatingHoldN/AView Rating Details
7/21/2016Wolfe ResearchDowngradeOutperform -> Peer PerformN/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingBuyN/AView Rating Details
2/2/2016WedbushLower Price TargetNeutral$130.00 -> $120.00N/AView Rating Details
(Data available from 1/18/2016 forward)

Earnings

Aetna (NYSE:AET) Earnings History and Estimates Chart

Earnings by Quarter for Aetna (NYSE:AET)

Aetna (NYSE AET) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/30/2018$1.18N/AView Earnings Details
10/31/2017Q3 2017$2.06$2.45$15.12 billion$14.99 billionViewN/AView Earnings Details
8/3/2017Q2 2017$2.34$3.42$15.34 billion$15.52 billionViewListenView Earnings Details
5/2/2017Q1 2017$2.36$2.71$15.39 billion$15.17 billionViewListenView Earnings Details
1/31/2017Q416$1.44$1.63$15.84 billion$15.73 billionViewListenView Earnings Details
10/27/2016Q316$2.02$2.07$15.71 billion$15.78 billionViewListenView Earnings Details
8/2/2016Q216$2.12$2.21$15.69 billion$15.95 billionViewListenView Earnings Details
4/28/2016Q116$2.23$2.30$15.46 billion$15.69 billionViewListenView Earnings Details
2/1/2016Q415$1.21$1.37$14.93 billion$15.09 billionViewListenView Earnings Details
10/29/2015Q315$1.77$1.90$15.22 billion$15.00 billionViewListenView Earnings Details
8/4/2015Q215$1.82$2.05$15.43 billion$15.13 billionViewListenView Earnings Details
4/28/2015Q115$1.96$2.39$15.48 billion$15.09 billionViewListenView Earnings Details
2/3/2015Q414$1.22$1.22$14.59 million$14.77 millionViewListenView Earnings Details
10/28/2014Q214$1.58$1.79$14.63 billion$14.70 billionViewListenView Earnings Details
7/29/2014Q114$1.61$1.69$13.98 billion$14.50 billionViewListenView Earnings Details
4/24/2014Q413$1.56$1.98$13.69 billion$13.97 billionViewListenView Earnings Details
2/6/2014Q313$1.36$1.34$13.14 billion$13.13 billionViewListenView Earnings Details
10/29/2013Q213$1.53$1.53$12.89 billion$12.99 billionViewListenView Earnings Details
7/30/2013Q2 2013$1.39$1.52$12.02 billion$11.56 billionViewListenView Earnings Details
4/30/2013Q1 2013$1.38$1.50$9.65 billion$9.51 billionViewListenView Earnings Details
1/31/2013Q4 2012$0.96$0.94$8.97 billion$8.96 billionViewListenView Earnings Details
10/25/2012Q312$1.34$1.55$8.96 billion$8.90 billionViewN/AView Earnings Details
7/31/2012$1.25$1.31ViewN/AView Earnings Details
4/26/2012$1.39$1.34ViewN/AView Earnings Details
2/1/2012$0.96$0.97ViewN/AView Earnings Details
10/27/2011$1.14$1.40ViewN/AView Earnings Details
7/27/2011$1.07$1.35ViewN/AView Earnings Details
4/28/2011$0.97$1.43ViewN/AView Earnings Details
2/4/2011$0.62$0.63ViewN/AView Earnings Details
11/3/2010Q3 2010$0.67$0.84ViewN/AView Earnings Details
7/27/2010Q2 2010$0.73$1.05ViewN/AView Earnings Details
4/29/2010Q1 2010$0.72$0.77ViewN/AView Earnings Details
2/5/2010Q4 2009$0.42$0.40ViewN/AView Earnings Details
10/29/2009Q3 2009$0.66$0.69ViewN/AView Earnings Details
7/27/2009Q2 2009$0.79$0.69ViewN/AView Earnings Details
4/29/2009Q1 2009$0.93$0.96ViewN/AView Earnings Details
2/12/2009Q4 2008$0.95$0.96ViewN/AView Earnings Details
10/29/2008Q3 2008$1.12$1.12ViewN/AView Earnings Details
7/31/2008Q2 2008$0.93$0.94ViewN/AView Earnings Details
4/24/2008Q1 2008$0.92$0.92ViewN/AView Earnings Details
2/7/2008Q4 2007$0.88$0.88ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Aetna (NYSE:AET) Earnings Estimates

2018 EPS Consensus Estimate: $10.69
2019 EPS Consensus Estimate: $11.11
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$2.75$2.80$2.78
Q2 20182$2.82$2.87$2.85
Q3 20182$2.67$2.81$2.74
Q4 20182$1.84$2.81$2.33
Q1 20191$3.03$3.03$3.03
Q2 20191$3.10$3.10$3.10
Q3 20191$2.94$2.94$2.94
Q4 20191$2.04$2.04$2.04
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Aetna (NYSE:AET) Dividend Information

Next Dividend:1/26/2018
Annual Dividend:$2.00
Dividend Yield:1.08%
Dividend Growth:24.80% (3 Year Average)
Payout Ratio:36.97% (Trailing 12 Months of Earnings)
20.45% (Based on This Year's Estimates)
19.25% (Based on Next Year's Estimates)
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Aetna (NYSE:AET)

Aetna (NYSE:AET) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
12/4/2017quarterly$0.501.12%1/10/20181/11/20181/26/2018
9/29/2017quarterly$0.501.25%10/11/201710/12/201710/27/2017
5/19/2017quarterly$0.501.42%7/11/20177/13/20177/28/2017
2/17/2017quarterly$0.501.58%4/11/20174/13/20174/28/2017
12/2/2016quarterly$0.250.77%1/10/20171/12/20171/27/2017
9/30/2016quarterly$0.250.87%10/11/201610/13/201610/28/2016
5/20/2016quarterly$0.250.91%7/12/20167/14/20167/29/2016
2/19/2016quarterly$0.250.94%4/12/20164/14/20164/29/2016
12/4/2015quarterly$0.250.97%1/12/20161/14/20161/29/2016
9/25/2015quarterly$0.250.95%10/13/201510/15/201510/30/2015
5/15/2015quarterly$0.250.88%7/14/20157/16/20157/31/2015
2/27/2015quarterly$0.251%4/7/20154/9/20154/24/2015
11/21/2014quarterly$0.251.15%1/13/20151/15/20151/30/2015
9/19/2014quarterly$0.231.08%10/14/201410/16/201410/31/2014
5/30/2014quarterly$0.231.16%7/8/20147/10/20147/25/2014
2/28/2014quarterly$0.231.25%4/8/20144/10/20144/25/2014
12/6/2013quarterly$0.231.35%1/14/20141/16/20141/31/2014
9/27/2013quarterly$0.201.25%10/8/201310/10/201310/25/2013
5/17/2013quarterly$0.201.35%7/9/20136/11/20137/26/2013
2/19/2013quarterly$0.201.66%4/9/20134/11/20134/26/2013
(Data available from 1/1/2013 forward)

Insider Trades

Aetna (NYSE AET) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.90%
Institutional Ownership Percentage: 87.69%
Insider Trades by Quarter for Aetna (NYSE:AET)
Insider Trades by Quarter for Aetna (NYSE:AET)

Aetna (NYSE AET) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/18/2017Karen S LynchPresidentSell15,271$161.91$2,472,527.6164,261View SEC Filing  
9/15/2017Margaret M MccarthyEVPSell10,288$162.85$1,675,400.8033,563View SEC Filing  
6/7/2017Margaret M MccarthyEVPSell27,028$149.23$4,033,388.4433,563View SEC Filing  
5/17/2017Mark T BertoliniChairmanSell103,547$140.79$14,578,382.13659,888View SEC Filing  
3/23/2017Shawn M GuertinInsiderSell29,602$129.35$3,829,018.7044,880View SEC Filing  
3/8/2017Francis S Soistman JrVPSell6,607$131.98$871,991.8623,454View SEC Filing  
9/7/2016Jeffrey E. GartenDirectorSell7,100$116.51$827,221.00View SEC Filing  
8/23/2016Shawn M GuertinInsiderSell45,328$120.21$5,448,878.8844,883View SEC Filing  
5/10/2016Margaret M MccarthyEVPSell39,169$114.45$4,482,892.0556,240View SEC Filing  
5/3/2016Mark T BertoliniCEOSell33,510$114.00$3,820,140.00496,588View SEC Filing  
3/15/2016Gary W LovemanEVPBuy8,970$111.45$999,706.509,605View SEC Filing  
2/22/2016Molly Joel CoyeDirectorSell1,175$106.28$124,879.008,104View SEC Filing  
12/23/2015Margaret M MccarthyEVPSell18,373$109.97$2,020,478.8163,515View SEC Filing  
12/22/2015Mark T. BertoliniCEOSell26,996$110.00$2,969,560.00729,194View SEC Filing  
8/14/2015Joseph M ZubretskyEVPSell179,087$118.66$21,250,463.42View SEC Filing  
8/13/2015Franklin Barbara HackmanDirectorSell2,064$118.47$244,522.08View SEC Filing  
3/31/2015Joseph M ZubretskyEVPSell200,000$107.96$21,592,000.00View SEC Filing  
3/27/2015Joseph M ZubretskyEVPSell86,958$107.24$9,325,375.92View SEC Filing  
3/26/2015Joseph M ZubretskyInsiderSell162,066$106.98$17,337,820.68View SEC Filing  
3/26/2015Margaret M MccarthyEVPSell27,670$106.04$2,934,126.80View SEC Filing  
3/25/2015Franklin Barbara HackmanDirectorSell3,000$108.75$326,250.00View SEC Filing  
3/17/2015William James CasazzaVPSell14,000$105.07$1,470,980.00View SEC Filing  
3/2/2015Molly Joel CoyeDirectorSell2,500$100.27$250,675.00View SEC Filing  
2/10/2015Rajan ParmeswarVPSell5,300$95.60$506,680.00View SEC Filing  
6/16/2014Molly Joel CoyeDirectorSell1,650$80.60$132,990.00View SEC Filing  
6/12/2014William James CasazzaVPSell15,906$80.58$1,281,705.48View SEC Filing  
5/27/2014Franklin Barbara HackmanDirectorSell2,665$77.26$205,897.90View SEC Filing  
2/19/2014Rajan ParmeswarVPSell3,600$69.46$250,056.003,829View SEC Filing  
12/30/2013Mark BertoliniCEOSell130,272$68.08$8,868,917.76526,938View SEC Filing  
12/27/2013William James CasazzaVPSell10,299$68.25$702,906.7533,903View SEC Filing  
8/26/2013William James CasazzaVPSell15,745$64.66$1,018,071.7033,903View SEC Filing  
6/18/2013William James CasazzaVPSell40,598$62.00$2,517,076.00View SEC Filing  
5/21/2013Molly Joel CoyeDirectorSell2,000$60.38$120,760.00View SEC Filing  
5/20/2013Joseph P NewhouseDirectorSell14,000$59.15$828,100.00View SEC Filing  
5/15/2013Rajan ParmeswarVPSell1,435$60.13$86,286.55View SEC Filing  
2/6/2013Karen RohanVPBuy4,035$49.53$199,853.55View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Aetna (NYSE AET) News Headlines

Source:
DateHeadline
BRIEF-Aetna Enhances Accountable Care Product In Connecticut With Trinity Health Of New EnglandBRIEF-Aetna Enhances Accountable Care Product In Connecticut With Trinity Health Of New England
www.reuters.com - January 18 at 3:23 PM
Why the amount of Americans with no insurance is growingWhy the amount of Americans with no insurance is growing
finance.yahoo.com - January 18 at 3:23 PM
 Analysts Anticipate Aetna Inc (AET) Will Announce Quarterly Sales of $14.89 Billion Analysts Anticipate Aetna Inc (AET) Will Announce Quarterly Sales of $14.89 Billion
www.americanbankingnews.com - January 18 at 9:40 AM
Monteverde & Associates PC Files Class Action Lawsuit On Behalf Of Shareholders Of Aetna, Inc In The District Of ... - PR Newswire (press release)Monteverde & Associates PC Files Class Action Lawsuit On Behalf Of Shareholders Of Aetna, Inc In The District Of ... - PR Newswire (press release)
www.prnewswire.com - January 18 at 7:52 AM
Monteverde & Associates PC Files Class Action Lawsuit On Behalf Of Shareholders Of Aetna, Inc In The District Of ConnecticutMonteverde & Associates PC Files Class Action Lawsuit On Behalf Of Shareholders Of Aetna, Inc In The District Of Connecticut
finance.yahoo.com - January 18 at 7:52 AM
Aetna Inc (AET) Expected to Post Q1 2019 Earnings of $3.03 Per ShareAetna Inc (AET) Expected to Post Q1 2019 Earnings of $3.03 Per Share
www.americanbankingnews.com - January 17 at 10:44 PM
Big Five MCOs on Pace to Beat Market in Medicare Advantage Growth for JanuaryBig Five MCOs on Pace to Beat Market in Medicare Advantage Growth for January
finance.yahoo.com - January 17 at 3:23 PM
Aetna to pay $17M over mailing that revealed HIV medsAetna to pay $17M over mailing that revealed HIV meds
marketbeat.com - January 17 at 1:46 PM
Aetna to Announce Fourth-Quarter and Full-Year 2017 ResultsAetna to Announce Fourth-Quarter and Full-Year 2017 Results
finance.yahoo.com - January 17 at 11:37 AM
Aetna Inc (AET) Given Consensus Rating of "Buy" by AnalystsAetna Inc (AET) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - January 16 at 1:38 AM
Aetna Inc (AET) Forecasted to Post Q1 2018 Earnings of $2.80 Per ShareAetna Inc (AET) Forecasted to Post Q1 2018 Earnings of $2.80 Per Share
www.americanbankingnews.com - January 15 at 5:40 AM
CVS plans to keep Aetnas headquarters in ConnecticutCVS plans to keep Aetna's headquarters in Connecticut
finance.yahoo.com - January 12 at 3:21 PM
CVS says it will keep Aetna in Connecticuts capital cityCVS says it will keep Aetna in Connecticut's capital city
marketbeat.com - January 12 at 1:09 PM
Aetna Target of Unusually High Options Trading (AET)Aetna Target of Unusually High Options Trading (AET)
www.americanbankingnews.com - January 12 at 1:28 AM
BRIEF-Aetna Says California Department Of Health Care Services Approves Aetnas Participation In Medi-CalBRIEF-Aetna Says California Department Of Health Care Services Approves Aetna's Participation In Medi-Cal
www.reuters.com - January 11 at 3:23 PM
Amid N.C.’s Medicaid reform, Aetna inks agreement with CCNCAmid N.C.’s Medicaid reform, Aetna inks agreement with CCNC
finance.yahoo.com - January 11 at 3:23 PM
Introducing Aetna Better Health® of CaliforniaIntroducing Aetna Better Health® of California
finance.yahoo.com - January 11 at 3:23 PM
Vitality Re IX $200m Health ILS From Aetna The First Deal Of 2018 - Seeking AlphaVitality Re IX $200m Health ILS From Aetna The First Deal Of 2018 - Seeking Alpha
seekingalpha.com - January 11 at 7:21 AM
New York City Halts $9.6 Million Incentive Package for Aetna Headquarters - Wall Street JournalNew York City Halts $9.6 Million Incentive Package for Aetna Headquarters - Wall Street Journal
www.wsj.com - January 11 at 7:21 AM
NYC halts $9.6M incentive package to move Aetna to cityNYC halts $9.6M incentive package to move Aetna to city
marketbeat.com - January 10 at 10:03 PM
AETNA Inc. Issues Positive Coverage Decision for ThyroSeq® Thyroid Genomic ClassifierAETNA Inc. Issues Positive Coverage Decision for ThyroSeq® Thyroid Genomic Classifier
www.prnewswire.com - January 10 at 3:23 PM
Aetna Inc. (AET) Ex-Dividend Date Scheduled for January 10, 2018 - NasdaqAetna Inc. (AET) Ex-Dividend Date Scheduled for January 10, 2018 - Nasdaq
www.nasdaq.com - January 10 at 7:44 AM
AbleTo, Inc. Announces James P. Bradley as Chairman of the BoardAbleTo, Inc. Announces James P. Bradley as Chairman of the Board
www.prnewswire.com - January 9 at 3:22 PM
CVS Could Climb Another 13% in 18: Morgan Stanley - Investopedia (blog)CVS Could Climb Another 13% in '18: Morgan Stanley - Investopedia (blog)
www.investopedia.com - January 9 at 7:57 AM
Contrasting Aetna (AET) & Coventry Health Care (CVH)Contrasting Aetna (AET) & Coventry Health Care (CVH)
www.americanbankingnews.com - January 8 at 1:40 PM
AET Ex-Dividend Reminder - 1/10/18 - NasdaqAET Ex-Dividend Reminder - 1/10/18 - Nasdaq
www.nasdaq.com - January 8 at 11:12 AM
Implied Volatility Surging for Aetna (AET) Stock Options - Nasdaq.com - NasdaqImplied Volatility Surging for Aetna (AET) Stock Options - Nasdaq.com - Nasdaq
www.nasdaq.com - January 6 at 3:22 PM
Aetna Inc (NYSE:AET): Can It Deliver A Superior ROE To The Industry?Aetna Inc (NYSE:AET): Can It Deliver A Superior ROE To The Industry?
finance.yahoo.com - January 6 at 7:48 AM
CVS Health expects tax overhaul to boost cash flow, shares rise - ReutersCVS Health expects tax overhaul to boost cash flow, shares rise - Reuters
www.reuters.com - January 5 at 7:27 AM
Aetna and CVS Were Talking to Others During Takeover Process ... - BloombergAetna and CVS Were Talking to Others During Takeover Process ... - Bloomberg
www.bloomberg.com - January 5 at 7:27 AM
Aetna and CVS Were Both Talking to Others During Deal ProcessAetna and CVS Were Both Talking to Others During Deal Process
finance.yahoo.com - January 5 at 7:27 AM
Implied Volatility Surging for Aetna (AET) Stock OptionsImplied Volatility Surging for Aetna (AET) Stock Options
finance.yahoo.com - January 4 at 3:22 PM
Want To Invest In Aetna Inc (NYSE:AET)? Here’s How It Performed LatelyWant To Invest In Aetna Inc (NYSE:AET)? Here’s How It Performed Lately
finance.yahoo.com - January 4 at 7:28 AM
UnitedHealth (UNH) Arm to Buy Chilean Company for $2.8BUnitedHealth (UNH) Arm to Buy Chilean Company for $2.8B
finance.yahoo.com - December 27 at 9:13 AM
What Is Aetna Inc’s (NYSE:AET) Share Price Doing?What Is Aetna Inc’s (NYSE:AET) Share Price Doing?
finance.yahoo.com - December 27 at 9:13 AM
Form 4 AETNA INC /PA/ For: Dec 19 Filed by: Jelinek Richard MForm 4 AETNA INC /PA/ For: Dec 19 Filed by: Jelinek Richard M
www.streetinsider.com - December 22 at 3:39 PM
Form 4 AETNA INC /PA/ For: Dec 19 Filed by: Jelinek Richard M - StreetInsider.comForm 4 AETNA INC /PA/ For: Dec 19 Filed by: Jelinek Richard M - StreetInsider.com
www.streetinsider.com - December 22 at 7:21 AM
Aetna Inc (AET) Receives Consensus Rating of "Buy" from AnalystsAetna Inc (AET) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - December 22 at 1:34 AM
Aetnas $640 Million CEO Is Overpaid By $440 Million - Seeking AlphaAetna's $640 Million CEO Is Overpaid By $440 Million - Seeking Alpha
seekingalpha.com - December 21 at 7:20 AM
Aetna (AET) Lowered to "Equal" at Morgan StanleyAetna (AET) Lowered to "Equal" at Morgan Stanley
www.americanbankingnews.com - December 20 at 12:08 PM
Humana, private equity firms buy Kindred Healthcare for $810 mlnHumana, private equity firms buy Kindred Healthcare for $810 mln
finance.yahoo.com - December 20 at 7:12 AM
RPT-U.S. employers say CVS-Aetna deal would affect health-benefits decisions -surveyRPT-U.S. employers say CVS-Aetna deal would affect health-benefits decisions -survey
www.businessinsider.com - December 19 at 3:22 PM
Insurer Humana pushes deeper into delivery of health careInsurer Humana pushes deeper into delivery of health care
marketbeat.com - December 19 at 3:18 PM
CVS CIO Stephen Gold Exits Ahead of Planned Aetna AcquisitionCVS CIO Stephen Gold Exits Ahead of Planned Aetna Acquisition
finance.yahoo.com - December 18 at 3:22 PM
U.S. employers say CVS-Aetna deal would affect health-benefits ... - ReutersU.S. employers say CVS-Aetna deal would affect health-benefits ... - Reuters
www.reuters.com - December 17 at 3:21 PM
Aetna Inc (AET) Expected to Post Quarterly Sales of $14.89 BillionAetna Inc (AET) Expected to Post Quarterly Sales of $14.89 Billion
www.americanbankingnews.com - December 15 at 6:24 AM
Form 4 AETNA INC /PA/ For: Dec 11 Filed by: SOISTMAN FRANCIS S JRForm 4 AETNA INC /PA/ For: Dec 11 Filed by: SOISTMAN FRANCIS S JR
www.streetinsider.com - December 14 at 3:22 PM
How a CVS-Aetna merger could change the health care scene in LouisvilleHow a CVS-Aetna merger could change the health care scene in Louisville
www.bizjournals.com - December 14 at 3:22 PM
Aetna Inc (AET) Expected to Post Earnings of $1.18 Per ShareAetna Inc (AET) Expected to Post Earnings of $1.18 Per Share
www.americanbankingnews.com - December 13 at 3:53 PM
Ascension, Providence St. Joseph in talks for mergerAscension, Providence St. Joseph in talks for merger
finance.yahoo.com - December 13 at 3:23 PM

SEC Filings

Aetna (NYSE:AET) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Aetna (NYSE:AET) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Aetna (NYSE AET) Stock Chart for Thursday, January, 18, 2018

Loading chart…

This page was last updated on 1/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.